Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NEWN Broke out with 8million shares on $1.4 earnings double-triple play potential
NEWN 3million shares only and earning 1.4 ashare . They sell iphone batterys
Iphone battery .. earnings 1.4 a share. Tomorrow will blast . Hitting 8 soon
NEWNI phone battery
The pilot program initially included one MeePower(R) product for the iPhone 3 and 4, but due to strong demand for the products, participating distributors have expanded MeePower(R)'s product offering to a total of five products and increased the number of China Unicom locations selling New Energy products from 3 to 39. The Company's distributors are actively looking to increase the number of China Unicom kiosks selling MeePower(R) products and further expand the numbers of models offered.
NEWN iphone battery
. "We are very pleased our distributors are now selling New Energy's MeePower(R)-branded products exclusively to China Unicom's kiosks. We believe China Unicom is the second largest mobile phone operator in China and the exclusive reseller of iPhones in China. We further believe China Unicom has an estimated 165 million mobile phone subscribers who are increasingly requiring the type of mobile power sources that New Energy manufactures,"
OMG I bought NEWN! only 3million shares and HIGH Earning . March 29 meeting we see this at 10
Yesterdays 30% gain was sweet Some shorted when we hit resistant at .495 today . They will probably cover befor end of day and buy back in pushing it back to .50+ cause good chance tomorrow is another green day.
REVU Double Triple play
Cause they Changed CEO who used to be CEO of EDGAR ONLINE
John M. Connolly, is our new ceo. Heacted as interim president of EDGAR® Online, Inc. (NASDAQ: EDGR since September 30, 2010. Till March 8 2011. Look at EDGR's Stock. It went from .75cent when the took over to $1.50Plus after he left and came to Princeton REVU.
http://www.edgar-online.com/About/PressR...
"John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001. "
REVU breaking out after they changed their CEO
John M. Connolly, is our new ceo. Heacted as interim president of EDGAR® Online, Inc. (NASDAQ: EDGR since September 30, 2010. Till March 8 2011. Look at EDGR's Stock. It went from .75cent when the took over to $1.50Plus after he left and came to Princeton REVU.
http://www.edgar-online.com/About/PressR...
"John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001. "
REVU breaking out. After they changed a thier CEO. New CEO was once CEO of EDGER online. and he made Edger go from .75 cent to 1.6 in 4 months
REVU Princeton Reviewbreaking out after they changed their CEO Princeton Review
Princeton Review Names Outsider As Interim CEO
Now - DJNF
DOW JONES NEWSWIRES
Princeton Review Inc. (REVU) named an outsider as its interim chief executive as current CEO Michael Perik departs to develop training programs for Middle Eastern health-care professionals.
John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001.
The board of the test-prep company formed a committee to immediately begin the search for a permanent CEO.
The company said Perik was leaving to pursue a new venture developing educational training programs in Middle Eastern countries for health-care professionals.
Later Wednesday, Princeton Review reported a flat loss for the fourth quarter before preferred-share effects, although revenue rose 24%.
Its shares closed Wednesday down 5.9% at 82 cents and weren't active after hours. The stock has fallen 80% in the last year.
-By Joan E. Solsman, Dow Jones Newswires; 212-416-2291; joan.solsman@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/nae/al?rnd=8VChBhdmMHQdBaWRcImUcg%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
03-09-11 1817ET
Copyright (c) 2011 Dow Jones & Company, Inc.
Princeton Review Names Outsider As Interim CEO
Now - DJNF
DOW JONES NEWSWIRES
Princeton Review Inc. (REVU) named an outsider as its interim chief executive as current CEO Michael Perik departs to develop training programs for Middle Eastern health-care professionals.
John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001.
The board of the test-prep company formed a committee to immediately begin the search for a permanent CEO.
The company said Perik was leaving to pursue a new venture developing educational training programs in Middle Eastern countries for health-care professionals.
Later Wednesday, Princeton Review reported a flat loss for the fourth quarter before preferred-share effects, although revenue rose 24%.
Its shares closed Wednesday down 5.9% at 82 cents and weren't active after hours. The stock has fallen 80% in the last year.
-By Joan E. Solsman, Dow Jones Newswires; 212-416-2291; joan.solsman@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/nae/al?rnd=8VChBhdmMHQdBaWRcImUcg%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
03-09-11 1817ET
Copyright (c) 2011 Dow Jones & Company, Inc.
REVU The Princeton Review, Inc 55Million share 41cent. will be back in dollars
John M. Connolly, is our new ceo. He acted as interim president of EDGAR® Online, Inc. (NASDAQ: EDGR since September 30, 2010. Till March 8 2011. Look at EDGR's Stock. It went from .75cent when he took over to $1.50Plus after he left and came to Princeton REVU.
http://www.edgar-online.com/About/PressR...
"John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001. "
REVU The Princeton Review, Inc55million share
.41cent Dollar soon
John M. Connolly, is our new ceo. He acted as interim president of EDGAR® Online, Inc. (NASDAQ: EDGR since September 30, 2010. Till March 8 2011. Look at EDGR's Stock. It went from .75cent when he took over to $1.50Plus after he left and came to Princeton REVU.
http://www.edgar-online.com/About/PressR...
"John M. Connolly most recently served as the interim CEO of Edgar Online Inc. (EDGR), which provides corporate information over the Internet gleaned from filings with the Securities and Exchange Commission. He also previously worked for Institutional Shareholder Services Inc.--which provides proxy voting, corporate governance, compliance and risk-management services--and founded Mainspring Inc., a corporate consultant that International Business Machines Corp. (IBM) purchased in 2001. "
CBLI, News Came out but didn't get PR yet!. Load up and get ready. Came out yesterday night they are sending medication to the japans gov.
http://biomedreports.com/2011031665069/tv-report-cleveland-biolabs-working-with-japanese-to-send-doses-of-radiation-antidote.html
this is just the start. Because The after math is clean up with health check. Medication will definitely be one of the concerns and Cleveland BioLabs, Inc. (CBLI) Have already contacted government agencies regarding these concerns. Will be looking green for the upcoming weeks due to after math
CBLI Gonna run! Fire at Japan nuclear reactor heightens radiation threat
http://www.reuters.com/article/2011/03/16/us-japan-quake-idUSTRE72A0SS20110316
Just now Nuclear warning to lvl 6. Lvl 7 is the highest
http://edition.cnn.com/2011/WORLD/asiapcf/03/15/japan.nuclear/?hpt=T2
Report: CBLI Officials in Touch With Appropriate Government Agencies as Japan's Nuclear Reactors Remain Unstable
http://edition.cnn.com/2011/WORLD/asiapcf/03/15/japan.nuclear/?hpt=T2
CBLI- Japan nuclear Reactor/ medicine/50million grant
Report: CBLI Officials in Touch With Appropriate Government Agencies as Japan's Nuclear Reactors Remain Unstable
56 minutes ago - Marketwire via Comtex
Marketwire
Officials at Cleveland Biolabs (NASDAQ: CBLI) continue to monitor the situation in Japan as U.S. Navy personnel have begun taking precautionary measures after instruments aboard an aircraft carrier docked in Japan detected some levels of radioactivity from the @#$%ushima Daiichi nuclear plant.
Various news reports out of that country indicate that workers continue scrambling to cool down fuel rods and prevent a full meltdown in three reactors at the earthquake-hit @#$%ushima Daiichi plant.
Japanese Prime Minister Naoto Kan warned Tuesday that the risk of further releases of radioactive material from the plant remains "very high."
"It really is difficult to interpret from the news what really is happening, government officials claim the situation is under control," said Cleveland Biolabs' CEO Michael Fonstein in an interview with BioMedReports. "The situation could deteriorate and someone should provide doses to protect the workers, so that they can be protected in case of exposure, regardless of deterioration. We believe our drug can help."
This past weekend, the company spent some time reaching out to officials, through the appropriate channels, to let them know that they were willing to donate doses of their CBLB502 radiation antidote. Extensive studies have demonstrated that CBLB502 is a very effective and non-toxic anti-radiation treatment which can increase the survival rates significantly after high doses of radiation.
"You know that there are certain U.S. agencies which are responsible for our own counter-measures and these same agencies are also responsible for dealing with international issues in this area, so we have been following clear protocols to make them aware that we have doses of CBLB502 which could be made available for potential emergency use."
"As far as getting into details as to which agencies we have been in contact with, I can only use the term 'appropriate U.S. agencies,'" explains Fonstein. "At this point I would not be comfortable to be more specific. We have actually made them aware that we do have doses available."
In addition, while the company said they had no additional update to provide, they continue to expect news about a pending $50+ million dollar grant from due from the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (DHHS). These monies are to be allocated for continued development of CBLB502 and will eventually lead to an RFP for the U.S. National Stockpile.
The full special report and interview with the Chief Executive Officer of Cleveland Biolabs is now available at:
http://biomedreports.com/2011031565038/c...
Investors interested in accessing BioMedReports' complete database of clinical trials and upcoming FDA decisions can go to:
http://biomedreports.com/access-our-excl...
News developments and live healthcare sector updates are available constantly via twitter at: http://twitter.com/BioMedReports
About BioMedReports.Com
BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets.
Media Contacts Only: Mary Davila Assistant Editor BioMedReports.Com e-mail: Email Contact Tel: +1 323 472 4480 Fax: +1 888 210 3556
SOURCE: BioMedReports
http://www2.marketwire.com/mw/emailprcnt...
CBLI's got my attention. Japan nuclear reactors going to cause radiation and this company has got medicine
CIGX Star, which plunged 73 percent the day after the 2009 ruling, rose 58 cents today, or 24 percent, to $2.95 at 5:20 p.m. New York time in Nasdaq Stock Market trading. IN 2009 was 5dollar, Cigx today who is in a better position. IT has a high chance for breaking 5dollar . GREEN!
CIGX Short squeeze coming After Hours Volume: 329,080 @ 3.05
CIGX Lawsuit against Reyholds $33
a share now. It'll be mid 3dollars or more depending on news next week load up
Star Scientific Shares Jump As Patent Claims Confirmed
53 minutes ago - DJNF
DOW JONES NEWSWIRES
Star Scientific Inc. (CIGX) said Friday the U.S. Patent & Trademark Office has confirmed the validity of the company's patents that are at the center of lawsuits filed against Reynolds American Inc. (RAI) in 2001 and 2002.
Shares of Star jumped 16% to $2.74 in recent trading, while Reynolds American's stock was down 0.4% at $33.61.
The technology-oriented tobacco company, which develops dissolvable smokeless tobacco products to prevent or reduce carcinogenic toxins in tobacco, is currently awaiting a ruling from the U.S. Court of Appeals of a jury verdict that was in favor of R.J. Reynolds Tobacco Co., a unit of Reynolds American.
In late 2009, a judge affirmed a federal jury's earlier ruling that R.J. Reynolds didn't infringe on Star's patent for a method of curing tobacco that reduces some toxins in the end product. In June of that year, a jury in Baltimore rejected Star's allegations that R.J. Reynolds encouraged its farmers to practice the company's curing invention without permission. Jurors ruled that R.J. Reynolds didn't infringe on Star's patent and that the patent was invalid. Star was seeking several hundred million dollars in damages.
Oral arguments on Star's appeal was heard by a three-judge panel of the Court of Appeals in January. The appeal requests that the jury verdict be reversed, as well as seeks a new District Court trial and be reassigned to a new judge.
On Friday, Star said the patent decision terminates a review sought by R.J. Reynolds, and that the decision can't be appealed. A Reynolds American representative wasn't immediately available to comment on the decision.
-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/nae/al?rnd=qpjd9t2w7rieHBdMjwy%2BAg%3D%3D. You can use this link on the day this article is published and the following day.
(END) Dow Jones Newswires
03-11-11 1411ET
Copyright (c) 2011 Dow Jones & Company, Inc.
cigx BACK IN 2.67 those patients back thier law suit. so if it goes. boom!@
Dont get me wrong. CIGX is still a star. I just failed my swing trade. It was red 3% and went up to 5% green. when i inform this board about the court letter it was only 1%green. I sold at 5% and it shot up to 25%. So if u had got in when i informed you would had been very green. IM still mad at my self. not sure if i will buy back in cause it shot up so much today. 25%!~!! I already made around 13,000 from CIGX..
As of now. I'll load up if it drops and if it keeps going up . Im taking it off my watch list.
I play on news. Im buying back in depending of the time. This is still a star. I sold at 2.5 and it shot to 2.7.
i just sold mines 2.5 will rebuy at lower or higher depending on news and volume
CIGX court letter. Load up before they PR it! it was sent yesterday but haven't been pr yet. Decisions up to you. Im in
NO need to thank me when it runs
http://intellectualvalue.org/wp-content/uploads/2011/03/90009372-NIRC.pdf
CIGX is up because it went from tabac, all the sudden to medical field. People in the medical field makes good money. and if it catches there attention, they will invest
as long thats there is volume along with a stock price trending up. Its a good and safe pick. accelerated speed and shares changing hand at a value higher. If price is up and no volume, then its another story
CIGX on another run... they delayed q4 to the 23rd. another 15% -20% green is possible
thanks
I can see a new pr for cigx already.
trading 8x above 30day avg volume at higher price means more green to come
my prediction of pr from Comtex SmarTrend(R)Lol
Buyers Accumulating Shares of Star Scientific on 8x Above-Average Volume (CIGX)
Shares of Star Scientific (NASDAQ:CIGX) are trading up 20% to $2.46 tApproximately 10 million shares have traded hands today vs. average 30-day volume of 1.4 million shares.
---------------------------------------------------
Today alot of people sold in and out and flipped. CIGX has now got massive attention. Once Fda approves or the slightest news. These people will come back driving share price higher and forcing massive short to covers. CIGX was shorted around the 2range . NOw its 2.46 as of this minute. Get ready for a blast from them covering mixed with new buyers coming in. FDA news and cure for memory lost is GOLDEN play, specially since company has 11million in cash and ceo bought shares also
GUYS im sorry for over hype. its because i know own so many shares from adding 3x's on CIGX. and a short squeeze is abouat to come. Price at 2.3 now. 12million shares shorted below 2 from past months. keep this up and OMG I will make so much from a potential short squeeze!
CIGX is on fire this morning. 12 million shorted shares. Most should have been shorted at below 2$. with this above 2 now. short squeeze will be coming soon if this keeps up. Green
AEZS went up tooo fast at pre. i didn't get a chance to loacd some! damn. Good thing CIGX is flying
remember my reply for your message on spex. i dont want to repost or it might seem like im bringing your stock down =P. Remember the Month MAY as a warning for spex, if you dont know ask me again then i will tell you
I was the one who brought up APRI to the board when it was only a dollar something. now its $5. CIGX is my next big star.
CIGX now has 11million cash in company, ceo bought shares with his own money. FDA on approval coming and cure for memory lost drug is under research. Potential of becoming a 2 digit stock like DNDN